Skip to main content
TipRanks
Go Ultimate75% OFF

Robert Shorr Insider Profile

4 Followers

Robert Shorr, Director at Brainstorm Cell Therapeutics, holds 45.73K shares in Brainstorm Cell Therapeutics (Ticker: BCLI).

Robert Shorr's Trading History

BCLI
Brainstorm Cell Therapeutics
Nov 13, 2017DirectorUninformative Buy―$45.27K
BCLI
Insider Shares: 45.73K (0.24%)
DateTransactionAmountNo. of SharesPrice per ShareProfitLink to Report
Nov 13, 2017Uninformative Buy$0.008,666$0.00―
Jun 23, 2016Uninformative Buy$0.008,666$0.00―
Dec 17, 2015Informative Sell$29.27K10,800$2.71+2.10%
Dec 14, 2015Informative Sell$28.47K10,800$2.63-1.10%
Aug 31, 2015Uninformative Buy$0.008,666$0.00―

You May Also Like

Robert Shorr insider profile FAQ

What is the percentage of profitable transactions made by Robert Shorr?
The percentage of profitable transactions made by Robert Shorr is 50%.
What is the average return per transaction made by Robert Shorr?
The average return per transaction made by Robert Shorr is 0.50%.
What stocks does Robert Shorr hold?
Robert Shorr holds: BCLI stocks.
What was Robert Shorr's most profitable transaction?
Robert Shorr’s most profitable transaction was an Informative Sell of BCLI stock on December 17, 2015. The return on the trade was 2.10%.
What is Robert Shorr's role in Brainstorm Cell Therapeutics?
Robert Shorr's role in Brainstorm Cell Therapeutics is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.